MC
IRMD icon

Menta Capital’s iRadimed IRMD Stock Holding History

Menta Capital’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-23,648
Closed -$879K – 603
2018
Q3 		$879K Sell
23,648
-41,148
-64% -$1.11M 0.31% 74
2018
Q2 		$1.34M Sell
64,796
-1,680
-3% -$29.7K 0.31% 63
2018
Q1 		$957K Sell
66,476
-500
-0.7% -$7.12K 0.2% 186
2017
Q4 		$1.01M Sell
66,976
-3,300
-5% -$41.9K 0.2% 183
2017
Q3 		$675K Sell
70,276
-200
-0.3% -$1.9K 0.1% 373
2017
Q2 		$606K Buy
70,476
+3,823
+6% +$32.6K 0.07% 467
2017
Q1 		$593K Buy
66,653
+13,339
+25% +$124K 0.06% 515
2016
Q4 		$592K Buy
53,314
+2,000
+4% +$21.5K 0.05% 579
2016
Q3 		$872K Buy
51,314
+9,395
+22% +$174K 0.08% 411
2016
Q2 		$912K Buy
41,919
+8,086
+24% +$145K 0.13% 277
2016
Q1 		$648K Buy
33,833
+5,230
+18% +$100K 0.09% 390
2015
Q4 		$802K Buy
28,603
+18,306
+178% +$518K 0.1% 333
2015
Q3 		$251K Buy
+10,297
New +$246K 0.04% 587

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
NA
Navellier & Associates Reno, Nevada $960M AUM 79.37% 1-Year Est. Return
CCM
Cadence Capital Management Boston, Massachusetts $415M AUM 11.01% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Menta Capital's IRMD Position: Q4 2018 in Review

Menta Capital sold out of iRadimed (IRMD) in Q4 2018, closing a stake of 23,648 shares — an estimated $879K sold.

Menta Capital first reported a position in IRMD in Q3 2015 and held it in 13 quarters. The position peaked at $1.34M in Q2 2018. 67 funds tracked by Wall St. Rank hold IRMD as of Q4 2018.

  • Menta Capital reported no remaining iRadimed position as of Q4 2018 after selling out during the quarter.
  • Menta Capital sold 23,648 iRadimed shares in Q4 2018, an estimated $879K.
  • Menta Capital first reported a position in iRadimed in Q3 2015 and held it in 13 quarters.
  • Menta Capital's iRadimed position peaked at $1.34M in Q2 2018.
  • 67 funds tracked by Wall St. Rank held iRadimed as of Q4 2018.

Based on Menta Capital's 13F filing for Q4 2018, filed 14 Feb 2019.